HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.

AbstractBACKGROUND:
In addition to androgens, growth factors are also implicated in the development and neoplastic growth of the prostate gland. Prosaposin is a potent neurotrophic molecule. Homozygous inactivation of prosaposin in mice has led to the development of a number of abnormalities in the male reproductive system, including atrophy of the prostate gland and inactivation of mitogen-activated protein kinase (MAPK) and Akt in prostate epithelial cells. We have recently reported that prosaposin is expressed at a higher level by androgen-independent (AI) prostate cancer cells as compared to androgen-sensitive prostate cancer cells or normal prostate epithelial and stromal cells. In addition, we have demonstrated that a synthetic peptide (prosaptide TX14A), derived from the trophic sequence of the saposin C domain of prosaposin, stimulated cell proliferation, migration and invasion and activated the MAPK signaling pathway in prostate cancer cells. The biological significances of saposin C and prosaposin in prostate cancer are not known.
RESULTS:
Here, we report that saposin C, in a cell type-specific and dose-dependent manner, acts as a survival factor, activates the Akt-signaling pathway, down-modulates caspase-3, -7, and -9 expression and/or activity, and decreases the cleaved nuclear substrate of caspase-3 in prostate cancer cells under serum-starvation stress. In addition, prosaptide TX14A, saposin C, or prosaposin decreased the growth-inhibitory effect, caspase-3/7 activity, and apoptotic cell death induced by etoposide. We also discovered that saposin C activates the p42/44 MAP kinase pathway in a pertussis toxin-sensitive and phosphatidylinositol 3-kinase (PI3K) /Akt-dependent manner in prostate cancer cells. Our data also show that the anti-apoptotic activity of saposin C is at least partially mediated via PI3K/Akt signaling pathway.
CONCLUSION:
We postulate that as a mitogenic, survival, and anti-apoptotic factor for prostate cancer cells, saposin C or prosaposin may contribute to prostate carcinogenesis at its early androgen-dependent or metastatic AI state.
AuthorsTae-Jin Lee, Oliver Sartor, Ronald B Luftig, Shahriar Koochekpour
JournalMolecular cancer (Mol Cancer) Vol. 3 Pg. 31 (Nov 17 2004) ISSN: 1476-4598 [Electronic] England
PMID15548330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromones
  • Culture Media, Serum-Free
  • Morpholines
  • Neoplasm Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Saposins
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Etoposide
  • Poly(ADP-ribose) Polymerases
  • Pertussis Toxin
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
  • Caspases
Topics
  • Apoptosis (drug effects, physiology)
  • Caspases (genetics)
  • Cell Line, Tumor
  • Cell Survival (genetics)
  • Chromones (pharmacology)
  • Culture Media, Serum-Free
  • Enzyme Activation (physiology)
  • Etoposide (antagonists & inhibitors, pharmacology)
  • Gene Expression Regulation, Enzymologic (physiology)
  • Gene Expression Regulation, Neoplastic (physiology)
  • Humans
  • Male
  • Mitogen-Activated Protein Kinases (metabolism)
  • Morpholines (pharmacology)
  • Neoplasm Proteins (physiology)
  • Pertussis Toxin (pharmacology)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Prostatic Neoplasms (enzymology, genetics)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Proto-Oncogene Proteins (antagonists & inhibitors, metabolism)
  • Proto-Oncogene Proteins c-akt
  • Saposins (physiology)
  • Signal Transduction (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: